Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1988 1
1990 1
1993 2
1994 2
1999 1
2000 1
2001 2
2002 1
2003 1
2008 1
2009 1
2010 2
2011 3
2012 9
2013 14
2014 24
2015 46
2016 45
2017 35
2018 36
2019 12
2020 18
2021 12
2022 3
2023 21
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

294 results

Results by year

Filters applied: . Clear all
Page 1
Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO.
Rossini D, Antoniotti C, Lonardi S, Pietrantonio F, Moretto R, Antonuzzo L, Boccaccino A, Morano F, Brugia M, Pozzo C, Marmorino F, Bergamo F, Tamburini E, Passardi A, Randon G, Murgioni S, Borelli B, Buonadonna A, Giordano M, Fontanini G, Conca V, Formica V, Aglietta M, Bordonaro R, Aprile G, Masi G, Boni L, Cremolini C. Rossini D, et al. J Clin Oncol. 2022 Sep 1;40(25):2878-2888. doi: 10.1200/JCO.22.00839. Epub 2022 Jun 6. J Clin Oncol. 2022. PMID: 35666229 Free PMC article. Clinical Trial.
No significant difference between arms was reported in terms of progression-free survival (median progression-free survival: 12.7 in the experimental group v 12.3 months in the control group, hazard ratio: 0.88, 95% CI, 0.70 to 1.11, P = .277). ...
No significant difference between arms was reported in terms of progression-free survival (median progression-free survival: 12.7 in the exp …
V-ATPase controls tumor growth and autophagy in a Drosophila model of gliomagenesis.
Formica M, Storaci AM, Bertolini I, Carminati F, Knævelsrud H, Vaira V, Vaccari T. Formica M, et al. Autophagy. 2021 Dec;17(12):4442-4452. doi: 10.1080/15548627.2021.1918915. Epub 2021 May 12. Autophagy. 2021. PMID: 33978540 Free PMC article.
In addition, downregulation of the V-ATPase subunit VhaPPA1-1 reduces Akt and Tor-dependent signaling and restores clearance. Consistent with evidence in flies, neurospheres from patients with high V-ATPase subunit expression show inhibition of autophagy. Altogether …
In addition, downregulation of the V-ATPase subunit VhaPPA1-1 reduces Akt and Tor-dependent signaling and restores clearance. Consist …
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling.
Formica V, Riondino S, Morelli C, Guerriero S, D'Amore F, Di Grazia A, Del Vecchio Blanco G, Sica G, Arkenau HT, Monteleone G, Roselli M. Formica V, et al. Br J Cancer. 2023 Aug;129(2):222-236. doi: 10.1038/s41416-023-02266-2. Epub 2023 Apr 20. Br J Cancer. 2023. PMID: 37081189 Free PMC article. Review.
Specific V-ATPase expression sub-classifies IDHwt lower-grade gliomas and impacts glioma growth in vivo.
Terrasi A, Bertolini I, Martelli C, Gaudioso G, Di Cristofori A, Storaci AM, Formica M, Bosari S, Caroli M, Ottobrini L, Vaccari T, Vaira V. Terrasi A, et al. EBioMedicine. 2019 Mar;41:214-224. doi: 10.1016/j.ebiom.2019.01.052. Epub 2019 Feb 5. EBioMedicine. 2019. PMID: 30737087 Free PMC article.
BACKGROUND: Cancer cells use specific V-ATPase subunits to activate oncogenic pathways. Therefore, we investigated V-ATPase deregulation in aggressive gliomas and associated signaling. ...In vivo, V-ATPase subunits deregulation significantly impacts tumor gro …
BACKGROUND: Cancer cells use specific V-ATPase subunits to activate oncogenic pathways. Therefore, we investigated V-ATPase de …
Dexamethasone and Surgical-Site Infection.
Corcoran TB, Myles PS, Forbes AB, Cheng AC, Bach LA, O'Loughlin E, Leslie K, Chan MTV, Story D, Short TG, Martin C, Coutts P, Ho KM; PADDI Investigators; Australian and New Zealand College of Anaesthetists Clinical Trials Network; Australasian Society for Infectious Diseases Clinical Research Network. Corcoran TB, et al. N Engl J Med. 2021 May 6;384(18):1731-1741. doi: 10.1056/NEJMoa2028982. N Engl J Med. 2021. PMID: 33951362 Clinical Trial.
A GBM-like V-ATPase signature directs cell-cell tumor signaling and reprogramming via large oncosomes.
Bertolini I, Terrasi A, Martelli C, Gaudioso G, Di Cristofori A, Storaci AM, Formica M, Braidotti P, Todoerti K, Ferrero S, Caroli M, Ottobrini L, Vaccari T, Vaira V. Bertolini I, et al. EBioMedicine. 2019 Mar;41:225-235. doi: 10.1016/j.ebiom.2019.01.051. Epub 2019 Feb 6. EBioMedicine. 2019. PMID: 30737083 Free PMC article.
We previously showed that some V-ATPase subunits are enriched in glioma stem cells and in patients with poor survival. In this study, we investigated how expression of a GBM-like V-ATPase pump influences the non-neoplastic brain microenvironment. ...
We previously showed that some V-ATPase subunits are enriched in glioma stem cells and in patients with poor survival. In this study, …
[Dialysis adequacy and Kt/V].
Formica M, Bosticardo G. Formica M, et al. G Ital Nefrol. 2011 Mar-Apr;28(2):152-6. G Ital Nefrol. 2011. PMID: 21488029 Italian.
The purpose of this paper is to evaluate, at a distance of about 30 years, the validity of the control parameter of dialysis - Kt/V - in 2010. In essence, the authors claim that Kt/V is of marginal utility in the quantification of traditional dialysis, while it is w …
The purpose of this paper is to evaluate, at a distance of about 30 years, the validity of the control parameter of dialysis - Kt/V - …
Catalytic enantioselective nucleophilic desymmetrization of phosphonate esters.
Formica M, Rogova T, Shi H, Sahara N, Ferko B, Farley AJM, Christensen KE, Duarte F, Yamazaki K, Dixon DJ. Formica M, et al. Nat Chem. 2023 May;15(5):714-721. doi: 10.1038/s41557-023-01165-6. Epub 2023 May 1. Nat Chem. 2023. PMID: 37127757 Free PMC article.
Here we introduce a catalytic and enantioselective strategy for the preparation of an enantioenriched phosphorus(V) centre that can be diversified enantiospecifically to a wide range of biologically relevant phosphorus(V) compounds. ...
Here we introduce a catalytic and enantioselective strategy for the preparation of an enantioenriched phosphorus(V) centre that can b …
The Relation Between Obesity and Mortality in Postcardiotomy Venoarterial Membrane Oxygenation.
Heuts S, Mariani S, van Bussel BCT, Boeken U, Samalavicius R, Bounader K, Hou X, Bunge JJH, Sriranjan K, Wiedemann D, Saeed D, Pozzi M, Loforte A, Salazar L, Meyns B, Mazzeffi MA, Matteucci S, Sponga S, Sorokin V, Russo C, Formica F, Sakiyalak P, Fiore A, Camboni D, Raffa GM, Diaz R, Wang IW, Jung JS, Belohlavek J, Pellegrino V, Bianchi G, Pettinari M, Barbone A, Garcia JP, Shekar K, Whitman G, Lorusso R; PELS-1 Investigators. Heuts S, et al. Ann Thorac Surg. 2023 Jul;116(1):147-154. doi: 10.1016/j.athoracsur.2023.03.025. Epub 2023 Apr 2. Ann Thorac Surg. 2023. PMID: 37015310
BACKGROUND: Obesity is an important health problem in cardiac surgery and among patients requiring postcardiotomy venoarterial extracorporeal membrane oxygenation (V-A ECMO). Still, whether these patients are at risk for unfavorable outcomes after postcardiotomy V-A …
BACKGROUND: Obesity is an important health problem in cardiac surgery and among patients requiring postcardiotomy venoarterial extracorporea …
Consensus based recommendations for diagnosis and medical management of Poland syndrome (sequence).
Baldelli I, Baccarani A, Barone C, Bedeschi F, Bianca S, Calabrese O, Castori M, Catena N, Corain M, Costanzo S, Barbato GP, De Stefano S, Divizia MT, Feletti F, Formica M, Lando M, Lerone M, Lorenzetti F, Martinoli C, Mellini L, Nava MB, Porcellini G, Puliti A, Romanini MV, Rondoni F, Santi P, Sartini S, Senes F, Spada L, Tarani L, Valle M, Venturino C, Zaottini F, Torre M, Crimi M. Baldelli I, et al. Orphanet J Rare Dis. 2020 Aug 5;15(1):201. doi: 10.1186/s13023-020-01481-x. Orphanet J Rare Dis. 2020. PMID: 32758259 Free PMC article. Review.
294 results